GLP-1 Providers in Nebraska (2026)

354 of the 444 sellers that publish a state list include Nebraska, the 22nd-most of the 50 states and DC. 226 of them ship to all 50 states, and 3 serve 15 states or fewer. Across the 243 with a regular monthly price, the middle figure is $170/mo.

Nebraska Medicaid does not pay for GLP-1 drugs prescribed only for weight loss. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

Sellers and prices are broken out by drug on the semaglutide in Nebraska and tirzepatide in Nebraska pages.

Who Ships GLP-1s to Nebraska

1. WellMedRx $49/mo
2. Collective $59/mo
3. CoreAge Rx $79/mo

Lowest regular prices for Nebraska: WellMedRx at $49/mo, Collective at $59/mo and CoreAge Rx at $79/mo.

Smaller-footprint sellers that include Nebraska: ZYP Medical (7 states), Limitless Male (9 states) and Onyx Weight Loss (9 states).

6 sellers that list 30 or more states leave Nebraska off, among them BMI Doctors, Mint Med, FormBlends, Care Clinics and Circle Medical.

Seller counts next door: Colorado 381, Iowa 358, Kansas 346, Missouri 349, South Dakota 340 and Wyoming 351.

Browse by medication

Nebraska Medicaid and GLP-1 Coverage

Nebraska Medicaid does not pay for GLP-1 drugs prescribed only for weight loss. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

• Wegovy to cut heart attack and stroke risk: covered with prior authorization (ages 45-74; no diabetes and HbA1c under 6.5%; BMI of at least 27 with a weight-related condition, or BMI of at least 30; 6 months of a medically supervised weight program; prior heart attack, prior stroke, or symptomatic peripheral artery disease (claudication with ABI under 0.85, or revascularization/amputation)).
• Wegovy for the liver disease MASH: covered with prior authorization (fibrosis stage F2, F3).
• Zepbound for obstructive sleep apnea: covered with prior authorization (an AHI of at least 15; a BMI of at least 30; PAP or an oral appliance must have failed or not been tolerated; PAP use means 4+ hours a night on 70% of nights for 2+ months).
• Weight-loss GLP-1s for adolescents: not covered.

In 2025, Nebraska Medicaid paid for at least 37,324 GLP-1 prescriptions, including at least 23,578 for Ozempic, at least 116 for Wegovy, 5,686 for Mounjaro and at least 355 for Zepbound, about $36.1 million before manufacturer rebates. Drugs labeled for weight loss made up 1% of that spending.

Medicaid rules checked November 2026. Prescription counts: CMS State Drug Utilization Data. Check your eligibility

Specialist Clinics and Obesity in Nebraska

Nebraska has 116 practices in the federal provider registry that list obesity medicine, endocrinology or bariatric care, 5.78 per 100,000 residents (47th of 51). By specialty: 60 bariatric, 55 endocrinology and 4 obesity medicine. About 37.6% of adults here had obesity in 2024 (CDC), the 7th-highest rate of the 50 states and DC. Measured against the median state, Nebraska has 1.62 times as much adult obesity per specialist practice.

Largest Cities in Nebraska

Frequently Asked Questions